The appropriate use of biomarkers in heart failure.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22980054.
- Also identified by DOI 10.1016/j.mcna.2012.07.002.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Natriuretic peptides and troponins have been extensively studied and used in heart failure, and their value has been extensively discussed. Renal markers, such as cystasin-C, NGAL, and KIM-1, have shown growing utility in heart failure. The activation of compensatory pathways and ongoing hemodynamic changes result in the release of biomarkers that can be monitored to chart disease progression and possibly target for therapy.
Medical subject headings
- Biomarkers
- Heart Failure
- Risk Assessment